LOS ANGELES--(BUSINESS WIRE)--NantHealth, a cloud-based information technology company, and NantOmics, a leading medical diagnostic company, both wholly owned subsidiaries of NantWorks, today provided information on the presentation of two abstracts at the 2015 American Society of Clinical Oncology (ASCO) annual meeting, May 29 to June 2, 2015, in Chicago. Abstract #11005 Title: “Protein expression by genetic mutations identified in gene panels (hotspots) and efficacy of targeted treatments.” S
| < Prev | Next > |
|---|
